title: Positive margins following surgical resection of breast carcinoma: analysis of pathologic correlates.
abstract: OBJECTIVE
  Histologic margin positivity represents a significant source of adverse clinical outcome affecting breast conservation therapy for in situ or invasive malignancy. Elucidation of factors associated with positive margin status might clarify and improve local therapy strategies. In order to define our experience with margin positivity and to identify relevant pathologic criteria, we retrospectively analyzed the cases of 143 patients who underwent resections for carcinoma with intent of breast conservation between 1995 and 1999.
  
  
  METHODS
  Histologic features and indices of biologic aggressiveness were compared among tumors resected with positive versus negative margins in order to determine whether such markers could be used to anticipate outcome.
  
  
  RESULTS
  Twenty-eight pathologic specimens were identified to possess histologically positive margins. Twenty-six patients underwent additional operative procedures. Of the 26 re-excision specimens, 17 (65%) contained residual malignancy. Statistical analysis demonstrated that margin positivity correlated with in situ histology and with Her 2/neu positivity.
  
  
  CONCLUSIONS
  These data suggest certain pathologic factors that may portend difficulty in achieving negative resection margins in patients in whom breast conservation therapy is considered.
authors.affiliation: Division of Surgical Oncology, Cancer Therapy and Research Center, San Antonio, Texas 78229-3900, USA. amiller@idd.org
authors.forename: Alexander R
authors.initials: AR
authors.lastname: Miller
authors.forename: Guillermo
authors.initials: G
authors.lastname: Brandao
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Prihoda
authors.forename: Cheryl
authors.initials: C
authors.lastname: Hill
authors.forename: Anatolio B
authors.initials: AB
authors.lastname: Cruz
authors.forename: I-Tien
authors.initials: IT
authors.lastname: Yeh
mesh_terms: D000368:Aged; D001943:Breast Neoplasms / Q000737:chemistry / Q000473:pathology* / Q000601:surgery*; D018270:Carcinoma, Ductal, Breast / Q000737:chemistry / Q000473:pathology / Q000601:surgery; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000737:chemistry / Q000473:pathology* / Q000601:surgery*; D005260:Female; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D008207:Lymphatic Metastasis; D015412:Mastectomy, Segmental; D008875:Middle Aged; D018365:Neoplasm, Residual; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases